about
SALL4, the missing link between stem cells, development and cancerSALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial CancerSerum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma.Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis.SALL4 is a novel therapeutic target in intrahepatic cholangiocarcinoma.Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta‑analysis of individual studiesSALL4 promotes gastric cancer progression through activating CD44 expressionMicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4Targeting SALL4 by entinostat in lung cancer.High expression of SALL4 and fascin, and loss of E-cadherin expression in undifferentiated/dedifferentiated carcinomas of the endometrium: An immunohistochemical and clinicopathologic study.Clinical translation for endometrial cancer stem cells hypothesis.Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?A New Indole Derivative Decreased SALL4 Gene Expression in Acute Promyelocytic Leukemia Cell Line (NB4)Aberrantly Expressed SALL4 Promotes Cell Proliferation via β-Catenin/c-Myc Pathway in Human Choriocarcinoma Cells.Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.Functional and clinical significance of SALL4 in breast cancer.The next new target in leukemia: The embryonic stem cell gene SALL4.The diagnostic and prognostic value of SALL4 in hepatoblastoma.The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells.Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis.Higher expression of SALL4 predicts poor cancer prognosis: A meta-analysis.SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis
P2860
Q28273464-5BCA2ABC-2C0D-4D06-A8EE-4A78D1C9B381Q28548494-516ED121-4036-4209-A729-DE2956685338Q33594153-A8986EF5-ABD6-4FA9-BBCB-7C8EA20FA43FQ33618541-2D8A4E3B-14BF-445B-A9FB-BBB033D0F8E8Q36413790-92084E46-1067-4092-88E1-D593727DF8DEQ36646122-72EF841C-F2A6-4CD5-868D-085230424C1DQ37024249-FB47B27B-3E87-46ED-AB84-ACACB33BA47AQ37269289-3FF8D7A2-C5F8-4987-BD9B-286740589426Q37479140-A9C6700D-A847-443E-9048-FE4FDD6427E1Q37687523-1E72B0EC-4FD7-4C2F-BEDD-EB8697B3EF75Q37688956-20460362-7D07-4F32-BF53-5674F97256D7Q37696856-4AB79E2B-13CB-4663-96DE-EAAA1460F677Q38557171-664950D9-6B37-41DC-A058-3FDBABD07B5CQ38584340-4B2BE970-68FF-40FF-B42D-A145CB7D973AQ38628583-26483C29-6306-4B77-A2CF-8F85A301703CQ38699429-2C02B9CE-1C56-4F71-9839-7BAADBA1FE39Q38802460-E5CC0B79-4D1F-41DB-9F0C-A2340B408F71Q38805786-5672A829-012E-4816-8F53-8E58238BF6D1Q40560744-FE559294-4B72-4E43-B5A9-C0A0C69BF8B9Q40723827-F0DAE429-7606-4507-84B0-7C6C911C74F5Q40946558-09EFECCE-CC90-42C6-A939-3AA8DCA43251Q40976297-BFDC3474-81F3-433A-ADB7-CA6A9651A227Q41470030-8CB0D0FD-D021-4F1E-AD82-B0046C72AC40Q42621065-19756E2E-BA12-4560-9381-4BDDEB3CEE7DQ45903019-85940307-1B2C-4C25-A013-C29B1DA30CADQ45990295-F58E6CE0-DA3F-4129-80A7-FF6F33987D11Q47747424-D7BC608E-3CA9-41C0-920E-ABFAC29181E2Q50958719-D4F05145-2249-4232-AD14-B1AB187745BCQ52597548-F9BED723-C924-42AD-9286-0C5AB425994EQ57816123-D29B1F53-9295-4F76-A54C-EA9BE5F3035B
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
SALL4 is a new target in endometrial cancer
@ast
SALL4 is a new target in endometrial cancer
@en
SALL4 is a new target in endometrial cancer
@nl
type
label
SALL4 is a new target in endometrial cancer
@ast
SALL4 is a new target in endometrial cancer
@en
SALL4 is a new target in endometrial cancer
@nl
prefLabel
SALL4 is a new target in endometrial cancer
@ast
SALL4 is a new target in endometrial cancer
@en
SALL4 is a new target in endometrial cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
SALL4 is a new target in endometrial cancer
@en
P2093
S Srivastava
P2860
P2888
P3181
P356
10.1038/ONC.2013.529
P407
P577
2013-12-16T00:00:00Z
P5875
P6179
1035120294